LY19-01c

Outcomes of Allogeneic Hematopoietic Cell Transplantation in Anaplastic Large Cell Lymphoma

Study #: LY19-01c

Study Status: Published

Presentation(s)

2022, EBMT (Oral)

Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.

Citation

Furqan F, Ahn KW, Chen Y, Kaur M, Abutalib SA, Ahmed N, Ahmed S, Kharfan-Dabaja MA, Friedberg J, Gregory T, Hill L, Sterling C, Barta SK, Shadman M, Perales MA, Zain J, Herrera AF, Sauter C, Hamadani M.

British Journal of Haematology. 2023, Jan 01: 200(1): 200(1):54-63. doi: 10.1111/bjh.18467. Epub 2022, Sep 19. PMCID:PMC9772096.

PubMed

PMID: 36120837

Abstract